Insiders · COEP

COEP insider transactions

Coeptis Therapeutics Holdings Inc. (COEP) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for COEP

• 2d
  SEC Form 4 filed by Director Sohn Adam Craig

  4 - Z Squared Inc. (0001759186) (Issuer)
• 2d
  SEC Form 4 filed by Chief Marketing Officer Schadel Christopher Ryan

  4 - Z Squared Inc. (0001759186) (Issuer)
• 2d
  SEC Form 4 filed by Director Fuerst Bryan Eric

  4 - Z Squared Inc. (0001759186) (Issuer)
• 2d
  SEC Form 4 filed by Co-Chief Executive Officer Halabu David Elias

  4 - Z Squared Inc. (0001759186) (Issuer)
• 2d
  SEC Form 4 filed by Director Cooper Kenneth Lyle

  4 - Z Squared Inc. (0001759186) (Issuer)
• 2d
  SEC Form 4 filed by Chief Financial Officer Cogley Brian

  4 - Z Squared Inc. (0001759186) (Issuer)
• 2d
  Co-Chief Executive Officer Burke Michelle Ellen was granted 16,447 shares (SEC Form 4)

  4 - Z Squared Inc. (0001759186) (Issuer)
• 2d
  SEC Form 3 filed by new insider Sohn Adam Craig

  3 - Z Squared Inc. (0001759186) (Issuer)
• 2d
  SEC Form 3 filed by new insider Schadel Christopher Ryan

  3 - Z Squared Inc. (0001759186) (Issuer)
• 2d
  New insider Halabu David Elias claimed ownership of 1,412,855 shares (SEC Form 3)

  3 - Z Squared Inc. (0001759186) (Issuer)
• 2d
  SEC Form 3 filed by new insider Fuerst Bryan Eric

  3 - Z Squared Inc. (0001759186) (Issuer)
• 2d
  SEC Form 3 filed by new insider Cooper Kenneth Lyle

  3 - Z Squared Inc. (0001759186) (Issuer)
• 2d
  SEC Form 3 filed by new insider Burke Michelle Ellen

  3 - Z Squared Inc. (0001759186) (Issuer)
• 77d
  Director Deschamps Philippe exercised 5,700 shares at a strike of $10.56 and was granted 3,250 shares, increasing direct ownership by 175% to 8,950 units (SEC Form 4)

  4 - Coeptis Therapeutics Holdings, Inc. (0001759186) (Issuer)
• 77d
  Chief Financial Officer Cogley Brian exercised 10,000 shares at a strike of $10.56 and was granted 12,500 shares, increasing direct ownership by 80% to 22,500 units (SEC Form 4)

  4 - Coeptis Therapeutics Holdings, Inc. (0001759186) (Issuer)
• 77d
  Director Cochran Christopher P. exercised 5,700 shares at a strike of $10.56 and was granted 3,250 shares, increasing direct ownership by 175% to 8,950 units (SEC Form 4)

  4 - Coeptis Therapeutics Holdings, Inc. (0001759186) (Issuer)
• 77d
  Director Salkind Gene exercised 5,700 shares at a strike of $10.56 and was granted 3,250 shares (SEC Form 4)

  4 - Coeptis Therapeutics Holdings, Inc. (0001759186) (Issuer)
• 77d
  Director Calise Chris exercised 5,700 shares at a strike of $10.56 and was granted 3,250 shares (SEC Form 4)

  4 - Coeptis Therapeutics Holdings, Inc. (0001759186) (Issuer)
• 77d
  VP Operations Yerace Daniel Alexander was granted 20,000 shares and exercised 10,000 shares at a strike of $10.41, increasing direct ownership by 17% to 70,531 units (SEC Form 4)

  4 - Coeptis Therapeutics Holdings, Inc. (0001759186) (Issuer)
• 77d
  CEO and President Mehalick David exercised 148,875 shares at a strike of $7.05 and was granted 51,250 shares, increasing direct ownership by 82% to 330,192 units (SEC Form 4)

  4 - Coeptis Therapeutics Holdings, Inc. (0001759186) (Issuer)
• 77d
  VP Compliance and Secy Sheehy Christine Elise exercised 1,000 shares at a strike of $10.56 and was granted 12,500 shares, increasing direct ownership by 2% to 64,031 units (SEC Form 4)

  4 - Coeptis Therapeutics Holdings, Inc. (0001759186) (Issuer)
• 77d
  Director Desilva Tara was granted 3,250 shares and exercised 5,700 shares at a strike of $10.56, increasing direct ownership by 175% to 8,950 units (SEC Form 4)

  4 - Coeptis Therapeutics Holdings, Inc. (0001759186) (Issuer)
• 417d
  SEC Form 4 filed by Director Deschamps Philippe

  4 - Coeptis Therapeutics Holdings, Inc. (0001759186) (Issuer)
• 421d
  SEC Form 4 filed by Chief Financial Officer Cogley Brian

  4 - Coeptis Therapeutics Holdings, Inc. (0001759186) (Issuer)
• 421d
  SEC Form 4 filed by VP of Operations Yerace Daniel Alexander

  4 - Coeptis Therapeutics Holdings, Inc. (0001759186) (Issuer)
• 421d
  SEC Form 4 filed by VP Compliance and Secy Sheehy Christine Elise

  4 - Coeptis Therapeutics Holdings, Inc. (0001759186) (Issuer)
• 421d
  SEC Form 4 filed by Director Salkind Gene

  4 - Coeptis Therapeutics Holdings, Inc. (0001759186) (Issuer)
• 421d
  SEC Form 4 filed by CEO and President Mehalick David

  4 - Coeptis Therapeutics Holdings, Inc. (0001759186) (Issuer)
• 421d
  SEC Form 4 filed by Director Desilva Tara

  4 - Coeptis Therapeutics Holdings, Inc. (0001759186) (Issuer)
• 421d
  SEC Form 4 filed by Director Cochran Christopher P.

  4 - Coeptis Therapeutics Holdings, Inc. (0001759186) (Issuer)
• 421d
  SEC Form 4 filed by Director Calise Chris

  4 - Coeptis Therapeutics Holdings, Inc. (0001759186) (Issuer)